MAIA Biotechnology, Inc. (MAIA) stock
MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.05 (+4.00%)
Close on Nov 18, 2026Market cap $79.07MP/E –Yield –
MAIA Biotechnology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MAIA Biotechnology's operating cash flow for the twelve months ending Jun 30, 2026 was -$22.57M. For fiscal 2025 it was -$18.84M. The highest annual figure on record is -$4.12M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.84M | – |
| FY2024 | Dec 31, 2024 | -$15.70M | – |
| FY2023 | Dec 31, 2023 | -$13.07M | – |
| FY2022 | Dec 31, 2022 | -$12.10M | – |
| FY2021 | Dec 31, 2021 | -$4.12M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.75M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.02M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.49M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.14M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.91M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.52M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.59M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.99M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.16M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.56M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.36M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.95M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.32M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.02M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.81M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.61M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.31M | – |
See a number that looks wrong?